Phase II study of bi-weekly CPT-11+CDDP for patients with gastric cancer refractory to S-1 (OGSG 0504 study)
国際学会発表
Multi-Center Phase II Study for Combination Therapy with Paclitaxel/Doxifluridine to Treat Advanced/Recurrent Gastric Cancer Showing Resistance to S-1 (OGSG0302)
Multi-center, phase II study for combination therapy with paclitaxel/doxifluridine to treat advanced/recurrent gastric cancer showing resistence to S-1: Final results (OGSG0302)
Muticenter Phase II Study of 2 Weeks Administration with TS-1 Followed by 1 Week Rest against Metastatic Gastric Cancer
Phase I/II study of combination chemotherapy with UFT/LV + CPT-11 in patients with advanced colorectal cancer (OGSG0303)
Multi-center, phase II study for combination therapy with pacritaxel/doxifluridine to treat advanced/recurrent gastric cancer showing resistance to S-1（OGSG0302）
Phase I/II Study of weekly Taxol(TXL) plus CPT-11 for patients with advanced/recurrent gastic cancer (AGC/RGC)
Phase II study of paclitaxel and doxifluridine in patients with S-1 failure gastric cancer
Phase II study of a new regimen for S-1 therapy aiming at adverse reaction mitigation for metastatic gastric cancer: a study by the Osaka Gastrointestinal Chemotherapy Study Group OGSG-0103
Phase I/II multicenter trial of S-1 plus paclitaxel in patients with metastatic gastric cancer: Osaka Gastrointestinal Cancer Chemotheraoy Study Group Study (OGSG 0105)